NeuroSearch A/S closes the sale of Huntexil® to Teva Pharmaceutical Industries Ltd. and adjusts the expectations to the full-year result

NeuroSearch A/S closes the sale of Huntexil® to Teva Pharmaceutical Industries Ltd. and adjusts the expectations to the full-year result

[at noodls] – Announcement 25.10.2012 Today, NeuroSearch A/S (OMX: NEUR) closed the asset transfer agreement with Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) concerning the sale of the Huntexil®project to Teva … more

View todays social media effects on TEVA

View the latest stocks trending across Twitter. Click to view dashboard

Share this post